GENE ONLINE|News &
T Cells and Cancer: Uncovering the Unknowns
T cells are potent cancer-killing immune cells but cancers have developed several ways to escape them. In recent years, immunotherapies such as CAR T cells and immune checkpoint inhibitors have reactivated the T cells to be effective against cancers. Understanding the interactions between cancer cells and T cells could help us develop novel therapeutics. Here we present key takeaways from the virtual AACR conference presentations that focussed on T Cells in Cancer.
GO Prime with only $1.49 now
LATEST
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
